| Primary |
| Hereditary Angioedema |
63.9% |
| Product Used For Unknown Indication |
25.0% |
| Angioedema |
2.1% |
| Anxiety |
1.5% |
| Enzyme Abnormality |
1.2% |
| Enzyme Level Decreased |
0.9% |
| Prophylaxis |
0.9% |
| Haemangioma Congenital |
0.6% |
| Hypertension |
0.6% |
| Muscle Spasms |
0.6% |
| Pain |
0.6% |
| Urticaria |
0.6% |
| Bronchospasm |
0.3% |
| Diabetes Mellitus |
0.3% |
| Gastrooesophageal Reflux Disease |
0.3% |
| Nasopharyngitis |
0.3% |
| Rhinitis |
0.3% |
|
| Drug Ineffective |
14.6% |
| Injection Site Pain |
13.1% |
| Injection Site Swelling |
8.5% |
| Hereditary Angioedema |
6.2% |
| Swelling |
5.4% |
| Abdominal Pain |
4.6% |
| Injection Site Rash |
4.6% |
| Off Label Use |
4.6% |
| Death |
3.8% |
| Injection Site Urticaria |
3.8% |
| Nausea |
3.8% |
| Diarrhoea |
3.1% |
| Injection Site Reaction |
3.1% |
| Malaise |
3.1% |
| Maternal Exposure During Pregnancy |
3.1% |
| Mental Disorder |
3.1% |
| Oedema Peripheral |
3.1% |
| Rash |
3.1% |
| Urticaria |
3.1% |
| Arteriospasm Coronary |
2.3% |
|
| Secondary |
| Product Used For Unknown Indication |
28.6% |
| Hereditary Angioedema |
25.7% |
| Muscle Spasms |
11.4% |
| Prophylaxis |
11.4% |
| Anxiety |
5.7% |
| Gastrooesophageal Reflux Disease |
5.7% |
| Nasopharyngitis |
5.7% |
| Pain |
5.7% |
|
| Gastroenteritis |
14.3% |
| Hereditary Angioedema |
14.3% |
| No Therapeutic Response |
14.3% |
| Pancreatitis |
14.3% |
| Prescribed Overdose |
14.3% |
| Thrombosis |
14.3% |
| Vision Blurred |
14.3% |
|
| Concomitant |
| Hereditary Angioedema |
38.2% |
| Product Used For Unknown Indication |
19.6% |
| Pain |
5.6% |
| Asthma |
5.4% |
| Prophylaxis |
5.1% |
| Depression |
4.0% |
| Abdominal Pain |
3.5% |
| Sleep Disorder |
2.2% |
| Systemic Lupus Erythematosus |
2.2% |
| Constipation |
1.9% |
| Gastrooesophageal Reflux Disease |
1.6% |
| Chronic Myeloid Leukaemia |
1.3% |
| Contraception |
1.3% |
| Hypersensitivity |
1.3% |
| Hypothyroidism |
1.3% |
| Convulsion |
1.1% |
| Diabetes Mellitus |
1.1% |
| Dyspnoea |
1.1% |
| Essential Hypertension |
1.1% |
| Hypertension |
1.1% |
|
| Therapy Change |
14.0% |
| Hereditary Angioedema |
11.6% |
| Pancreatitis |
9.3% |
| Therapy Regimen Changed |
9.3% |
| Tooth Abscess |
9.3% |
| Inappropriate Schedule Of Drug Administration |
7.0% |
| Off Label Use |
4.7% |
| Oxygen Saturation Abnormal |
4.7% |
| Urinary Tract Infection |
4.7% |
| Angioedema |
2.3% |
| Chest Discomfort |
2.3% |
| Chest Pain |
2.3% |
| Dysarthria |
2.3% |
| Dyspnoea |
2.3% |
| Gastric Ulcer |
2.3% |
| Headache |
2.3% |
| Hemiparesis |
2.3% |
| Hospitalisation |
2.3% |
| Hypersensitivity |
2.3% |
| Hypovolaemic Shock |
2.3% |
|
